<DOC>
	<DOCNO>NCT00043030</DOCNO>
	<brief_summary>RATIONALE : Understanding patient participate phase I clinical trial may help doctor plan well treatment cancer . PURPOSE : This clinical trial study determine reason participation , perception , expectation patient receive treatment cancer phase I clinical trial .</brief_summary>
	<brief_title>Evaluating Patient Participation Phase I Clinical Trials</brief_title>
	<detailed_description>OBJECTIVES : - Describe motivation , perception , expectation patient enrol phase I clinical trial . - Assess influence age , education , gender upon perception patient . - Compare difference perception , motivation , expectation patient previously participate phase I clinical trial v . - Determine whether patient ' perception , motivation , expectation change enrolled phase I clinical trial . - Validate interviewer-administered tool measure perception , motivation , expectation patient . - Assess patient ' perception information give enrol phase I clinical trial . OUTLINE : Patients interview phone evaluate perception , motivation , expectation phase I clinical trial . Patients complete questionnaire comprise 24 question 30-45 minute . Interviews conduct within 1 week enrol phase I clinical trial ( prior first dose study agent ) 2 month later ( time patient stop treatment ) . The first 10 patient enrol complete additional 6 question 15 minute first interview validate questionnaire , complete second interview . PROJECTED ACCRUAL : A total 120 patient accrue study within 1 year .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Enrolled phase I clinical trial within past week Signed informed consent phase I trial PATIENT CHARACTERISTICS : Age 18 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Able follow basic verbal instruction witness investigator representative Able understand speak English determine investigator representative Access telephone PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other Prior participation phase I clinical trial allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>